Ignacio Jesús
Dávila González
Catedrático de Universidad
Publicaciones (259) Publicaciones de Ignacio Jesús Dávila González
2024
-
Impact of the ERS/ATS 2022 Guidelines for Interpretation of Lung Function Test Results When Assessing the Response to Biologics in Asthma
Journal of Investigational Allergology and Clinical Immunology
-
Regional, sex, and age inequities in asthma hospital admissions in Spain and Portugal
Clinical and Translational Allergy
2023
-
A Prospective Study of Costs Associated With the Evaluation of Allergic Reactions to Radiological Contrast Media
Journal of investigational allergology & clinical immunology, Vol. 33, Núm. 2, pp. 102-108
-
ALERGODATA: Sentinel Registry of Health Outcomes in Allergic Patients Treated With Biological Therapies at Specialized Allergology Clinics in Spain
Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 6, pp. 479-482
-
An Exceptional Case of Recall Phenomenon to Hypersensitivity to Amoxicillin
Dermatitis, Vol. 34, Núm. 5, pp. 452-453
-
Avances en el manejo del asma difícil de tratar y asma grave
Optimizando el abordaje del asma bronquial (Universidad Internacional de Andalucía), pp. 177-188
-
Basic assessment of chronic cough in primary care and referral pathways of patients to different specialists
Therapeutic Advances in Respiratory Disease, Vol. 17
-
Biological treatments for asthma
The Dangers of Allergic Asthma (Nova Science Publishers, Inc.), pp. 265-283
-
Burden of refractory and unexplained chronic cough on patients’ lives: a cohort study
ERJ Open Research, Vol. 9, Núm. 5
-
Characteristics and Management of Patients with Refractory or Unexplained Chronic Cough in Outpatient Hospital Clinics in Spain: A Retrospective Multicenter Study
Lung, Vol. 201, Núm. 3, pp. 275-286
-
Contact Palpebral Dermatitis and Conjunctivitis Due to Delayed Hypersensitivity to Timolol
Dermatitis
-
Correspondence regarding the paper “Laorden D, Zamarrón E, Romero D, Domínguez-Ortega J, Villamañán E, Losantos I, Gayá F, Quirce S, Álvarez-Sala R. Evaluation of FEOS score and super-responder criteria in a real-life cohort treated with anti-IL5/IL5R. Respir. Med. 2023; 211: 107216”
Respiratory Medicine
-
Interleukin 5 Receptor Subunit Alpha Expression as a Potential Biomarker in Patients with Nasal Polyposis
Biomedicines, Vol. 11, Núm. 7
-
Quantitative and qualitative methods of evaluating response to biologics in severe asthma patients: Results from a real-world study
Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 3, pp. 949-951.e2
-
RNY3 modulates cell proliferation and IL13 mRNA levels in a T lymphocyte model: a possible new epigenetic mechanism of IL-13 regulation
Journal of Physiology and Biochemistry, Vol. 79, Núm. 1, pp. 59-69
-
Report of two sisters with Netherton syndrome successfully treated with dupilumab and review of the literature
International Journal of Immunopathology and Pharmacology, Vol. 37
-
Response to Monoclonal Antibodies in Asthma: Definitions, Potential Reasons for Failure, and Therapeutic Options for Suboptimal Response
Journal of investigational allergology & clinical immunology, Vol. 33, Núm. 1, pp. 1-13
-
Role of Different Health Care Professionals in the Management of Asthma Patients: The GEMA-FORUM IV Task Force
Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 3, pp. 214-217
-
The Importance of Preventing and Managing Tear Dysfunction Syndrome in Allergic Conjunctivitis and How to Tackle This Problem
Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 6, pp. 439-445
-
Transcriptomics reveals new regulatory mechanisms involved in benralizumab response
Allergy: European Journal of Allergy and Clinical Immunology